Article By:
Tyler Durden
Sunday, March 10, 2024 1:00 PM EDT
Shares of clinical stage biopharmaceutical company MindMed were heavily monitored on Friday after the stock rocketed higher during Thursday's cash session by more than 51% on more than 30x the company's average volume.
In this article: MNMD